Page last updated: 2024-08-25

5-hydroxymethylcytosine and Experimental Hepatoma

5-hydroxymethylcytosine has been researched along with Experimental Hepatoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Briedé, JJ; Claessen, SMH; Deferme, L; Kleinjans, JCS; van Breda, SG; van den Beucken, T; Wagner, RJ; Wolters, JEJ1
Bian, XW; Bie, P; Chen, X; Cui, Y; Liu, C; Liu, L; Qian, C; Shan, J; Shen, J; Wu, L; Xia, F; Xu, Y; Yang, Z1
Drake, AJ; Illingworth, RS; Kerr, AR; Lempiäinen, H; Lyall, MJ; Meehan, RR; Moggs, JG; Muller, A; Ottaviano, R; Schwarz, M; Terranova, R; Thomson, JP; Unterberger, EB; Webb, S; Wolf, CR1

Other Studies

3 other study(ies) available for 5-hydroxymethylcytosine and Experimental Hepatoma

ArticleYear
A cross-omics approach to investigate temporal gene expression regulation by 5-hydroxymethylcytosine via TBH-derived oxidative stress showed involvement of different regulatory kinases.
    Toxicology in vitro : an international journal published in association with BIBRA, 2018, Volume: 48

    Topics: 5-Methylcytosine; Animals; Gene Expression Regulation; Gene Regulatory Networks; Genomics; Hep G2 Cells; Humans; Liver Neoplasms, Experimental; Metabolome; Microarray Analysis; Oxidative Stress; Protein Kinases; RNA; tert-Butylhydroperoxide

2018
Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.
    PloS one, 2013, Volume: 8, Issue:5

    Topics: 5-Methylcytosine; Animals; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cytosine; Diethylnitrosamine; Dioxygenases; Disease Progression; DNA Methylation; DNA-Binding Proteins; Down-Regulation; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Middle Aged; Mixed Function Oxygenases; Prognosis; Proto-Oncogene Proteins; Rats, Wistar

2013
Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver Cancer.
    Cancer research, 2016, 05-15, Volume: 76, Issue:10

    Topics: 5-Methylcytosine; Animals; Carcinoma, Hepatocellular; Cell Differentiation; CpG Islands; DNA Methylation; DNA-Binding Proteins; Histones; Liver Neoplasms, Experimental; Mice; Promoter Regions, Genetic; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured

2016